Related Experiment Videos
[Chemiluminescent immunoassay for insulin]
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|September 1, 1991
Summary
This study presents a solid-phase chemiluminescent immunoassay for detecting insulin using a novel antibody labeling method. The assay demonstrates high sensitivity and a wide linear range for accurate insulin quantification.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Context:
- Accurate insulin measurement is crucial for diabetes management and research.
- Existing immunoassays may have limitations in sensitivity or dynamic range.
- Development of sensitive and reliable diagnostic tools is an ongoing need.
Purpose:
- To develop and validate a solid-phase chemiluminescent immunoassay for insulin detection.
- To utilize N-(4-aminobutyl)-N-ethylisoluminol (ABE1) labeled antibodies for enhanced signal generation.
- To establish the assay's performance characteristics, including linear range and limit of detection.
Summary:
- A solid-phase chemiluminescent immunoassay for insulin was developed using N-(4-aminobutyl)-N-ethylisoluminol (ABE1) labeled antibodies and a double antibodies sandwich technique.
- The chemiluminescent system employed was ABEI-CoCl2-H2O2, providing a sensitive detection method.
- The assay achieved a linear range of 0.3-150 microU/tube with a high correlation coefficient (0.985) and an absolute limit of detection of 0.32 microU/tube.
Impact:
- This assay offers a highly sensitive and reliable method for insulin quantification.
- The developed immunoassay can aid in clinical diagnostics and pharmacokinetic studies.
- The findings contribute to the advancement of chemiluminescent immunoassay technology for biomarker detection.